Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Market Capitalization on January 27, 2025: USD 324.22 M

Lifecome Biochemistry Co.,Ltd. Market Capitalization is USD 324.22 M on January 27, 2025, a -19.65% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Lifecome Biochemistry Co.,Ltd. 52-week high Market Capitalization is USD 451.07 M on March 11, 2024, which is 39.12% above the current Market Capitalization.
Lifecome Biochemistry Co.,Ltd. 52-week low Market Capitalization is USD 244.38 M on September 18, 2024, which is -24.63% below the current Market Capitalization.
Lifecome Biochemistry Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 335.80 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years